| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/13/2006 | US7060272 Death domain containing receptor-4 agonist antibodies and methods |
| 06/13/2006 | US7060271 Specifically bind to the extracellular domain of the human type beta PDGF receptor; diagnostic and therapeutic uses |
| 06/13/2006 | US7060266 Human brain carboxypeptidase B |
| 06/13/2006 | US7060264 use of patatin and structurally related proteins which have insect inhibitory properties; Coleoptera; monocotyledons; |
| 06/13/2006 | US7060261 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders |
| 06/13/2006 | US7060249 Obtaining and identifying drosophila neurodegeneration mutant which demonstrates temperature-sensitive and bang-sensitive paralysis phenotypes; neuroprotectants |
| 06/13/2006 | US7060247 Metal complexed with chelating group attached to gastrin releasing peptide receptor agonist which includes a bombesin agonist binding moiety; for use as therapeutic or diagnostic radiopharmaceutical |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/13/2006 | CA2155434C Prohormone convertase transformed cells and polypeptide synthesis |
| 06/13/2006 | CA2064761C Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
| 06/13/2006 | CA1341508C Transforming growth factor peptides |
| 06/08/2006 | WO2006060799A2 Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis |
| 06/08/2006 | WO2006060743A2 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 06/08/2006 | WO2006060680A2 Mda-7 protein variants having antiproliferative activity |
| 06/08/2006 | WO2006060643A2 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 06/08/2006 | WO2006060630A2 Apparatuses and methods for determining protease activity |
| 06/08/2006 | WO2006060044A1 Toxin compounds with enhanced membrane translocation characteristics |
| 06/08/2006 | WO2006060021A2 Bifunctional fusion proteins containing the flt3 ligand |
| 06/08/2006 | WO2006059959A1 Nogo a protein fragments as neuronal network-interacting peptides |
| 06/08/2006 | WO2006059914A1 Modulation of ovulation |
| 06/08/2006 | WO2006059913A1 Modulation of ovulation |
| 06/08/2006 | WO2006059638A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | WO2006059529A1 Hla-a24-restricted tumor antigen peptide |
| 06/08/2006 | WO2006059130A2 Manipulation of starch granule size and number (ii) |
| 06/08/2006 | WO2006059125A2 Tumour suppressor genes |
| 06/08/2006 | WO2006059113A2 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 06/08/2006 | WO2006059105A2 Non-cytotoxic Protein Conjugates |
| 06/08/2006 | WO2006059093A2 Fusion proteins |
| 06/08/2006 | WO2006059081A2 Methods of treatment using melanopsin |
| 06/08/2006 | WO2006058760A2 Bacterial insecticidal proteins |
| 06/08/2006 | WO2006058620A2 Method for producing carboxy-terminal amidified peptides |
| 06/08/2006 | WO2006058496A1 Mimic antigen epitope of her-2 and composition which comprise such epitope |
| 06/08/2006 | WO2006058359A2 Protein allergen derivatives |
| 06/08/2006 | WO2006037570A3 Protein assay of type sglt1 |
| 06/08/2006 | WO2006035060A3 Purification of a bulk of a factor vii polypeptide by fractionated elution from an anion-exchange material |
| 06/08/2006 | WO2006035058A3 Purification of a drug substance of a factor vii polypeptide by removal of desgla-factor vii polypeptide structures |
| 06/08/2006 | WO2006032923A3 Inhibitors of protein kinase a anchoring |
| 06/08/2006 | WO2006032232A3 Novel lysolipin biosynthesis gene cluster |
| 06/08/2006 | WO2006027571A3 Insect sucrase |
| 06/08/2006 | WO2006021800A3 Tumour model |
| 06/08/2006 | WO2006018428A3 Hemopexin fusion proteins |
| 06/08/2006 | WO2006017788A3 TRANSGENIC HFN4α MICE EXPRESSING THERAPEUTIC TARGET AF1 DOMAINS AND THEIR METHODS OF USE AS MODELS FOR METABOLIC DISORDERS |
| 06/08/2006 | WO2006014234A3 Novel recombinant poxvirus composition and uses thereof |
| 06/08/2006 | WO2006013010A3 Preparation of organisms with faster growth and/or higher yield |
| 06/08/2006 | WO2006008163A3 Recombinant spider silk proteins |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2006000464A3 Method for discovering pain-relevant substances using pain-relevant proteins |
| 06/08/2006 | WO2005123762B1 Codon-optimized HPV16 li for salmonella vaccine strains against human papillomavirus type 16 |
| 06/08/2006 | WO2005118820A8 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 06/08/2006 | WO2005116067A3 Msh-agonist tripeptide conjugates |
| 06/08/2006 | WO2005116052A3 ANTAGONISM OF TGF-β SUPERFAMILY RECEPTOR SIGNALING |
| 06/08/2006 | WO2005113585A3 Modified tgf-beta superfamily polypeptides |
| 06/08/2006 | WO2005111079A3 Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 |
| 06/08/2006 | WO2005097818A3 An assay system for screening protease inhibitors |
| 06/08/2006 | WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/08/2006 | WO2005090393A3 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 06/08/2006 | WO2005078105A3 Selection markers useful for heterologous protein expression |
| 06/08/2006 | WO2005072385A3 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 06/08/2006 | WO2005069900A3 Npc1l1 (npc3) and methods of identifying ligands thereof |
| 06/08/2006 | WO2005047487B1 Motoneuronotrophic factor gene sequences |
| 06/08/2006 | WO2005023862A9 Homogeneous preparations of IL-28 and IL-29 |
| 06/08/2006 | WO2005023191A3 Rage-related methods and compositions for treating glomerular injury |
| 06/08/2006 | WO2005010197A3 A systemic small rna signaling system in plants |
| 06/08/2006 | WO2004087866A3 Methods for the identification of inhibitors of lipid transfer protein activity in plants |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123512 novel DNA probes useful in detecting a nucleic acid sequence encoding a novel Lepidopteran- and Coleopteran-active delta -endotoxin polypeptide. Also disclosed are nucleic acid detection methods and kits involving the novel DNA probes. |
| 06/08/2006 | US20060123511 Plant regulatory sequences for selective control of gene expression |
| 06/08/2006 | US20060123509 Protein isolation and purification |
| 06/08/2006 | US20060123507 Gene elevating cereal yield and utilization thereof |
| 06/08/2006 | US20060123506 Regulation of gene expression using chromatin remodelling factors |
| 06/08/2006 | US20060123505 Full-length plant cDNA and uses thereof |
| 06/08/2006 | US20060123497 Sperm-specific cation channel, catsper-4, and uses therefor |
| 06/08/2006 | US20060123496 Animal models |
| 06/08/2006 | US20060123495 Knockout mice and their use |
| 06/08/2006 | US20060123492 Methods of identifying modulators of NMUR2-mediated activity |
| 06/08/2006 | US20060122380 Novel human secreted proteins and polynucleotides encoding the same |
| 06/08/2006 | US20060122375 Plant stress tolerance genes, and uses therefor |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122373 Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060122371 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same |
| 06/08/2006 | US20060122370 Specific binding agents of human angiopoietin-2 |
| 06/08/2006 | US20060122368 Antigen delivery platform |
| 06/08/2006 | US20060122135 Cloning and expression of a novel member of the Glial cell-line derived neurotrophic factors (GDNF); Parkinson's , Alzheimer's , Huntington's, Creutzfeld-Jacob diseases, neuropathic pain; acute brain injury, multiple sclerosis, amyotrophic lateral sclerosis, peripheral nerve trauma; cancer |
| 06/08/2006 | US20060122132 Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer |
| 06/08/2006 | US20060122121 Modified alpha-MSH peptides and derivatives thereof |
| 06/08/2006 | US20060122119 Peptides for use in antitumor immunotherapy |
| 06/08/2006 | US20060122114 Antibodies to heregulin 2 |
| 06/08/2006 | US20060122113 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof |
| 06/08/2006 | US20060122111 Regeneration and neogenesis of retinal visual cell otx2 gene |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060122106 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 06/08/2006 | US20060122096 Reversible modification of amine-containing compounds |
| 06/08/2006 | US20060121591 Mutant proteinase-inhibitors and uses thereof |
| 06/08/2006 | US20060121573 Production of proteins |
| 06/08/2006 | US20060121572 Production of heterologous proteins in Caulobacter |
| 06/08/2006 | US20060121568 Production of polypeptides |
| 06/08/2006 | US20060121566 Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor |
| 06/08/2006 | US20060121565 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 06/08/2006 | US20060121564 Novel expression vector suitable for expression of recombinant protein at low temperature |